Broad project biology and small molecule and antibody therapeutic drug discovery experience from project inception through to early development. Significant contributions to projects in bone, inflammation, immunology, oncology, immuno-oncology, and neuro-degradation/neuro-inflammation therapeutic areas. Strong organizational leadership of groups and individuals, having built high-performing teams. The breadth and depth of experience needed to provide both the high level and very detailed guidance needed to drive discovery programs and translational programs. Strengths include project biology through DC selection, translational biology, pre-clinical pharmacology, disease and target engagement biomarkers, authoring of pharmacology and other appropriate sections for CTA, IND, IB and other regulatory submissions. Managed collaborations with key opinion leaders and academic collaborators. Utilized internal resources and a network of Contract Research Organizations (CROs) to achieve project goals. Participated in the due diligence process across multiple successful deals.My success has been documented as an author on impactful papers, patents, invited presentations, and importantly drug discovery programs that have progressed into and through development. Specialties: Antibody therapeutic discovery, protein therapeutic discovery, small molecule therapeutic discovery, biologics, inflammation, cancer, bone biology, Protein-protein interaction biacore, molecular biology, assay development, cell based assays, primary cell assays, enzymology, kinase, protein production, protein purification, pathway biology, HPLC, FPLC, ELISA, FRET, Lable free assays, High content assays (Cellomics).